Alterity Therapeutics Limited (ATHE) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access ATHE Annual Balance Sheets →
Quarterly balance sheet trends provide context on Alterity Therapeutics Limited's liquidity, leverage, and long-term financial structure.
Quarterly Report, GAAP in USD millions
ITEM
(Jun 30 2025)
0 0 0 (Jun 30 2024)
Assets
Cash And Cash Equivalents21.80
Cash & Short-term Investments21.00
Trade & Other Current Receivables (IFRS combined total)-
Other Current Assets8.36
Total Current Assets30.15
Equipment/Property/Plant Net0.00
Tax Assets, Noncurrent32.79
Other Assets, Noncurrent0.10
Total Assets30.25
Liabilities
Accounts Payable1.69
Current Tax Liabilities0.01
Other Liabilities, Current0.04
Current Provisions0.58
Total Current Liabilities2.32
Total Long-term Debt0.00
Noncurrent Provisions0.06
Total Liabilities2.38
Stockholders' Equity
Other Equity27.87
Common Stockholder's Equity27.87
Total Stockholder's Equity27.87
Liabilities & Stockholder's Equity30.25
4 historic quarters locked

Sign in to unlock the full Alterity Therapeutics Limited balance sheet history.

About Alterity Therapeutics Ltd Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 20-F filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001437749-26-029135

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.